Home » Newsletters » BioWorld Science

BioWorld Science

June 2, 2014

View Archived Issues

AAV-mediated bevacizumab therapy tested in ovarian cancer model

InterMune develops novel pirfenidone analogues with improved efficacy and safety profile

XOMA presents a novel anti-TGF-beta MAb for the treatment of proliferative vitreoretinopathy

Amgen reports results from OSLER study of evolocumab

Shionogi and University of Tokyo present carnosadine lactam derivatives

Tetraphase Pharmaceuticals reports on preclinical testing of second-generation tetracyclines

U.S. investigators report discovery of Myc inhibitors for cancer

Boehringer Ingelheim prepares and tests new CMV inhibitors

First clinical data on LJM-716 reported at ASCO

Toyama Chemical and Fujifilm patent novel TNF-alpha inhibitors

arGEN-X collaborates with Bayer to discover and develop therapeutic antibodies

Psyadon initiates phase IIb study of ecopipam for Tourette's syndrome in children

Jacobus Pharmaceutical divulges compounds for malaria

Array BioPharma and Biogen Idec form collaboration targeting autoimmune disorders

Topical HDAC inhibitor shows efficacy in CTCL

Roche designs new PDE10A inhibitors for psychiatric and other disorders

Intensity Therapeutics and NCI establish CRADA to study in situ chemovaccination technology

Dr. Falk Pharma plans phase III trial of phosphatidylcholine in ulcerative colitis

Phase I study to begin of BAY-1161909 in combination with paclitaxel in advanced malignancies

Zydus initiates phase III trial of saroglitazar in lipodystrophy

Korean Drug Development Fund and Celerion form collaboration to support early-stage research

Fibrocell and Intrexon contract Progenitor Cell Therapy to produce epidermolysis bullosa therapy

Oncothyreon and Celldex Therapeutics to collaborate on trial of ONT-10 and varlilumab

FDA approves Aloxi for pediatric use

FDA approves blood test to diagnose primary MGN

FDA accepts for review Genzyme's sBLA resubmission for Lemtrada

ANG-1005 awarded U.S. fast track and orphan drug designations for glioblastoma multiforme

Astellas and UMN submit Japanese filing for influenza vaccine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...